Christopher Kulp
Richman Chemical Inc.
768 N. Bethlehem Pike
Suite 204
Lower Gwynedd, PA 19002
Phone:
(215) 628-2946
Fax:
(215) 664-9598
E-mail: clk@richmanchemical.com
Web Page: www.richmanchemical.com
Specialties:
- Biotechnology
- Pharmaceutical
- Virtual Start-ups
- Custom Synthesis
- Toll Manufacturing
- Project Management
- Product Development
Services and Expertise:
- cGMP (all scales)
- Reference Standards
- Chiral Compounds
- Mg to MT scales
- Multi-step Organic Synthesis
- Commercial Production
- Process development
- Difficult Separations
- Pharma Intermediates and APIs
- Raw Material and Intermediate Sourcing
- Logistics coordination services
- Regulatory compliance monitoring and filing
Richman Chemical, Inc. (RCI) specializes in custom contract manufacturing projects (unit operation and pharmaceutical cGMP processing included) and the sourcing of hard-to-find chemicals. Our focus is on value-added custom synthesis and efficient sourcing solutions on any scale, while always providing expert project management along the way. With this foundation, we have built a well-deserved reputation for excellence as an ideal partner for emerging technology companies. Moreover, we have forged numerous strong alliances with start-up biotech and life science firms looking to accelerate their development and commercialization strategies. Our goal is to help our clients successfully navigate the outsourcing maze in an optimized and successful manner!
For a complete list of our capabilities and services, please visit us at www.richmanchemical.com.
Christopher Kulp - Director, Contract Services Business Chris has been with RCI for ten years and has thirteen years of experience in development and manufacturing within the pharmaceutical and chemical industries. He has four U.S. patents and two European patents to his credit and contributed to successful commercialization efforts in the areas of natural and synthetic polymers, organometallics, and pharmaceuticals. Chris earned his M.S. in Polymer Chemistry from Stevens Institute of Technology after completing his undergraduate work in Chemistry at the University of Delaware. Additionally, he holds an MBA in Finance from the Fox School of Business at Temple University.
